 |
|
Survival outcomes and toxicity of intraoperative intraperitoneal chemotherapy in advanced epithelial ovarian cancer
Ji-Young Yoon, Yu-Jin Koo, Mi-Jung Kim, Tae-Jin Kim, Kyung-Taek Lim, Ki-Heon Lee
Obstet Gynecol Sci. 2014;57(6):484-491. Published online 2014 Nov 20 DOI: https://doi.org/10.5468/ogs.2014.57.6.484
|
|
Citations to this article as recorded by
 Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis
Qin Tang, Mao Huang, Jing Zhang, Zhen Huang, Linlian Wang, Zhengxin Gong, Liangdan Tang
Journal of Clinical Medicine.2023; 12(3): 1111. CrossRef Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences
Yuanming Shen, Sangsang Tang, Junfen Xu, Xing Xie, Zhongbo Chen
Frontiers in Medicine.2022;[Epub] CrossRef Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
Daniele Marrelli, Luca Ansaloni, Orietta Federici, Salvatore Asero, Ludovico Carbone, Luigi Marano, Gianluca Baiocchi, Marco Vaira, Federico Coccolini, Andrea Di Giorgio, Massimo Framarini, Roberta Gelmini, Carmen Palopoli, Fabio Accarpio, Anna Fagotti
Cancers.2022; 14(23): 6010. CrossRef Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial Ovarian Carcinoma
Ga Won Yim, Kyung Jin Eoh, Sang Wun Kim, Eun Ji Nam, Young Tae Kim
Nutrition and Cancer.2016; 68(5): 772. CrossRef Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
Mingchen Ba, Hui Long, Xiangliang Zhang, Yunqiang Tang, Yinbing Wu, Shuai Wang, Zhaofei Yan, Bohuo Zhang, Shuzhong Cui
International Journal of Gynecologic Cancer.2016; 26(9): 1571. CrossRef
|